person · Reporting owner
Rosebrough Walter M Jr
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COOPER COMPANIES, INC.COO · Entity 3395 | Director | September 11, 2026 | September 15, 2026 |
| STERIS plcSTE · Entity 3228 | Director · President & CEO | November 09, 2020 | November 10, 2020 |
| Varex Imaging CorpVREX · Entity 5135 | Director | February 12, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COOPER COMPANIES, INC.
Report date September 11, 2026 · Filed September 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirectsee footnote | 20,000 |
Last balance in matching sequence
After 2026-09-14 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 2 · 2026-09-11 · Purchase · Acquired 7,000 · Balance 17,000 F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $53.15 to $54.50. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2: Shares held by the Walter M Rosebrough, Jr Revocable Trust, of which the Reporting Person is sole trustee. Row 3 · 2026-09-14 · Purchase · Acquired 3,000 · Balance 20,000 F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $54.00 to $54.44. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2: Shares held by the Walter M Rosebrough, Jr Revocable Trust, of which the Reporting Person is sole trustee. |
| Common StockSEC Table I · non-derivative | Direct | 832 |
Reported balance
Holding disclosure · report date 2026-09-11 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 832 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $53.15 to $54.50. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2: Shares held by the Walter M Rosebrough, Jr Revocable Trust, of which the Reporting Person is sole trustee.
F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $54.00 to $54.44. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
STERIS plc
Report date November 09, 2020 · Filed November 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 58,391 |
Reported balance
After 2020-11-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-11-09 · Sale · Disposed 3,014 · Balance 58,391 F1: Price reflects a weighted average sale price for multiple transactions ranging from $192.66 to $193.64 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 51,605 |
Reported balance
After 2020-11-09 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2020-11-09 · Sale · Disposed 6,786 · Balance 51,605 F2: Price reflects a weighted average sale price for multiple transactions ranging from $193.83 to $194.71 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 51,405 |
Reported balance
After 2020-11-09 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2020-11-09 · Sale · Disposed 200 · Balance 51,405 F3: These 51,405 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. F4: 26,853 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 2,217 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; 2,217 on June 1, 2022; 2,597 on May 31, 2023; 2,217 on June 1, 2023; and 2,217 on June 3, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Price reflects a weighted average sale price for multiple transactions ranging from $192.66 to $193.64 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2: Price reflects a weighted average sale price for multiple transactions ranging from $193.83 to $194.71 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3: These 51,405 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit.
F4: 26,853 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 2,217 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; 2,217 on June 1, 2022; 2,597 on May 31, 2023; 2,217 on June 1, 2023; and 2,217 on June 3, 2024.
Varex Imaging Corp
Report date February 12, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 14,947 |
Reported balance
After 2026-02-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-12 · Grant · Acquired 14,947 · Balance 14,947 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis.
F2: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 1
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 48,895 · Balance 0 F1: These 48,895 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 37,375 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,625 on May 28, 2019; 4,000 on May 30, 2019; 3,097 on May 31, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021 and 3,097 on May 31, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | IndirectSee Footnote Below. | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 13,000 · Balance 0 F3: These ordinary shares are held by the reporting person's spouse as trustee of a revocable trust established for her benefit. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30 | Direct | 0 |
Reported balance
After 2018-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-03-28 · Disposition to issuer · Disposed 119,000 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 119,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.98 · Expires 2025-08-10 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-28 · Disposition to issuer · Disposed 111,000 · Balance 0 F5: This option will become exercisable as follows: 27,750 on May 28, 2016; 27,750 on May 28, 2017; 27,750 on May 28, 2018 and 27,750 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 111,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2026-06-01 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-28 · Disposition to issuer · Disposed 112,340 · Balance 0 F6: This option becomes exercisable as follows: 28,085 on June 1, 2017; 28,085 on June 1, 2018; 28,085 on June 3, 2019 and 28,085 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 112,340 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.07 · Expires 2027-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-28 · Disposition to issuer · Disposed 136,000 · Balance 0 F7: This option becomes exercisable as follows: 34,000 on May 30, 2018; 34,000 on May 30, 2019; 34,000 on June 1, 2020 and 34,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-28 · Disposition to issuer · Disposed 136,268 · Balance 0 F8: This option becomes exercisable as follows: 34,067 on May 31, 2019; 34,067 on June 1, 2020; 34,067 on June 1, 2021 and 34,067 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,268 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
Filing footnotes · ownership attribution and instrument terms
F1: These 48,895 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 37,375 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,625 on May 28, 2019; 4,000 on May 30, 2019; 3,097 on May 31, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021 and 3,097 on May 31, 2022.
F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F3: These ordinary shares are held by the reporting person's spouse as trustee of a revocable trust established for her benefit.
F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 119,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F5: This option will become exercisable as follows: 27,750 on May 28, 2016; 27,750 on May 28, 2017; 27,750 on May 28, 2018 and 27,750 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 111,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F6: This option becomes exercisable as follows: 28,085 on June 1, 2017; 28,085 on June 1, 2018; 28,085 on June 3, 2019 and 28,085 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 112,340 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F7: This option becomes exercisable as follows: 34,000 on May 30, 2018; 34,000 on May 30, 2019; 34,000 on June 1, 2020 and 34,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F8: This option becomes exercisable as follows: 34,067 on May 31, 2019; 34,067 on June 1, 2020; 34,067 on June 1, 2021 and 34,067 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,268 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 28, 2019 Filed Mar 28, 2019 14:03 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerOrdinary Shares, 10 pence par value | 13,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021564 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 0 F3 · shares: These ordinary shares are held by the reporting person's spouse as trustee of a revocable trust established for her benefit. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3 · ownership.nature: These ordinary shares are held by the reporting person's spouse as trustee of a revocable trust established for her benefit. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:03 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerOrdinary Shares, 10 pence par value | 48,895 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021564 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: These 48,895 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 37,375 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,625 on May 28, 2019; 4,000 on May 30, 2019; 3,097 on May 31, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021 and 3,097 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document |
| March 21, 2019 Filed Mar 22, 2019 21:01 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $45.34 | $0.00 |
DisclosureSEC source: 0001209191-19-021015 · doc4.xml · derivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 50,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 100,000 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 100,000 STERIS Corporation common shares for $45.34 per share, subject to the same terms and conditions as the original STERIS stock option. Read SEC document |
| March 21, 2019 Filed Mar 22, 2019 21:01 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 50,000 | $125.00 | $6,250,000.00 |
DisclosureSEC source: 0001209191-19-021015 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,895 F1 · shares: This exercise and sale of a total of 50,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 28, 2018. F3 · balance_after: These 48,895 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 37,375 of these Ordinary Shares are restricted. The restrictions on the restricted Ordinary Shares lapse as follows: 3,625 on May 28, 2019; 4,000 on May 30, 2019; 3,097 on May 31, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021 and 3,097 on May 31, 2022. Read SEC document |
| March 21, 2019 Filed Mar 22, 2019 21:01 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 50,000 | $45.34 | $2,267,000.00 |
DisclosureSEC source: 0001209191-19-021015 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 50,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 28, 2018. F2 · shares: This option to purchase 100,000 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 100,000 STERIS Corporation common shares for $45.34 per share, subject to the same terms and conditions as the original STERIS stock option. Read SEC document |
| February 14, 2019 Filed Feb 20, 2019 00:57 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 5,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-19-000025 · wf-form4_155062422418756.xml · derivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,098 Underlying: Common Stock · 5,098 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 3 years from grant date, (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 3 years from grant date, (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 21:27 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $29.94 | $0.00 |
DisclosureSEC source: 0001209191-18-061268 · doc4.xml · derivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 18,000 shares Expires 2022-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option to purchase 18,000 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 18,000 STERIS Corporation common shares for $29.94 per share, subject to the same terms and conditions as the original STERIS stock option. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 21:27 UTC | STERIS plc STE · Entity 158792 | GiftOrdinary Shares, 10 pence par value | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-061268 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 13,000 F3 · shares: This gift of a total of 5,000 shares, held by the Reporting Person's Spouse as Trustee of a revocable trust established for her benefit, was pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person's Spouse, as Trustee, on November 28, 2018. F4 · ownership.nature: These ordinary shares are held by the Reporting Person's Spouse as Trustee of a revocable trust established for her benefit. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 21:27 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 18,000 | $120.00 | $2,160,000.00 |
DisclosureSEC source: 0001209191-18-061268 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,895 F1 · shares: This exercise and sale of a total of 18,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 28, 2018. F2 · balance_after: These 48,895 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 37,375 of these Ordinary Shares are restricted. The restrictions on the restricted Ordinary Shares lapse as follows: 3,625 on May 28, 2019; 4,000 on May 30, 2019; 3,097 on May 31, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021 and 3,097 on May 31, 2022. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 21:27 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 18,000 | $29.94 | $538,920.00 |
DisclosureSEC source: 0001209191-18-061268 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 18,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 28, 2018. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 21:33 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 10,000 | $120.50 | $1,205,000.00 |
DisclosureSEC source: 0001209191-18-057751 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 18,000 F2 · shares: This sale of a total of 10,000 shares, held by the Reporting Person's Spouse as Trustee of a revocable trust established for her benefit, was pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person's Spouse, as Trustee, on May 21, 2018. F3 · ownership.nature: These ordinary shares are held by the Reporting Person's Spouse as Trustee of a revocable trust established for her benefit. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 21:34 UTC | Varex Imaging Corp VREX · Entity 5135 | PurchaseCommon Shares | 10,000 | $28.39 | $283,900.00 |
DisclosureSEC source: 0001681622-18-000028 · wf-form4_153385042927150.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions: 5,000 shares at a price of $28.00 and 5,000 shares at a price of $28.78. F2 · balance_after: These 14,000 Common Shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. Read SEC document |
| July 13, 2018 Filed Jul 16, 2018 20:52 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 10,000 | $110.50 | $1,105,000.00 |
DisclosureSEC source: 0001209191-18-042649 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 28,000 F3 · shares: This sale of a total of 10,000 shares, held by the Reporting Person's Spouse as Trustee of a revocable trust established for her benefit, was pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person's Spouse, as Trustee, effective on May 21, 2018. F4 · ownership.nature: These ordinary shares are held by the Reporting Person's Spouse as Trustee of a revocable trust established for her benefit. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 20:46 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 2,100 | $104.57 | $219,597.00 |
DisclosureSEC source: 0001209191-18-035166 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,521 F3 · shares: 2,100 shares were withheld from the 4,681 restricted shares that vested on June 1, 2018. These 2,100 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,681 ordinary shares were awarded to Mr. Rosebrough on June 1, 2016 as part of an award of 18,724 restricted shares. These vested shares were valued at the NYSE closing market price on June 1, 2018. The remaining restrictions on these ordinary shares lapse as follows: 4,681 on June 3, 2019; and 4,681 on June 1, 2020. F4 · balance_after: These 50,521 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 37,375 of these Ordinary Shares are restricted. The restrictions on the restricted Ordinary Shares lapse as follows: 3,625 on May 28, 2019; 4,000 on May 30, 2019; 3,097 on May 31, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021 and 3,097 on May 31, 2022. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 20:46 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 8,571 | $104.46 | $895,326.66 |
DisclosureSEC source: 0001209191-18-035166 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,621 F2 · price: This represents the average sales price of the 8,571 shares sold in the open market. The actual sales prices ranged from $104.16 per share to $104.77 per share. The Reporting Person, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of the separate sales prices Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:46 UTC | STERIS plc STE · Entity 158792 | GrantEmployee Stock Option (right to buy) · Derivative | 136,268 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001209191-18-035166 · doc4.xml · derivative · entry 5 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,268 Underlying: Ordinary Shares · 136,268 shares Expires 2028-05-31 F6 · derivative.exercise_date: This option becomes exercisable as follows: 34,067 on May 31, 2019; 34,067 on June 1, 2020; 34,067 on June 1, 2021 and 34,067 on May 31, 2022. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:46 UTC | STERIS plc STE · Entity 158792 | GiftOrdinary Shares, 10 pence par value | 5,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-035166 · doc4.xml · nonDerivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 38,000 F5 · ownership.nature: These ordinary shares are held by the Reporting Person's Spouse as Trustee of a revocable trust established for her benefit. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:46 UTC | STERIS plc STE · Entity 158792 | GrantOrdinary Shares, 10 pence par value | 12,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-035166 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,192 F1 · shares: All 12,388 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 3,097 on May 31, 2019; 3,097 on June 1, 2020; 3,097 on June 1, 2021 and 3,097 on May 31, 2022. Read SEC document |
| May 30, 2018 Filed May 31, 2018 21:15 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 2,211 | $104.57 | $231,204.27 |
DisclosureSEC source: 0001209191-18-034412 · doc4.xml · nonDerivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,894 F4 · shares: 2,211 shares were withheld from the 4,000 restricted shares that vested on May 30, 2018. These 2,211 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,000 ordinary shares were awarded to Mr. Rosebrough on May 30, 2017 as part of an award of 16,000 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2018. The remaining restrictions on these ordinary shares lapse as follows: 4,000 on May 30, 2019; 4,000 on May 30, 2020; and 4,000 on May 30, 2021. F5 · balance_after: These 45,894 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 29,668 of these Ordinary Shares are restricted. The restrictions on the restricted Ordinary Shares lapse as follows: 4,681 on June 1, 2018; 3,625 on May 28, 2019; 4,000 on May 30, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020 and 4,000 on June 1, 2021. Read SEC document |
| May 30, 2018 Filed May 31, 2018 21:15 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 2,842 | $104.57 | $297,187.94 |
DisclosureSEC source: 0001209191-18-034412 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,105 F3 · shares: 2,842 shares were withheld from the 4,250 restricted shares that vested on May 30, 2018. These 2,842 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,250 ordinary shares were awarded to Mr. Rosebrough on May 30, 2014 as part of an award of 17,000 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2018. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 20:52 UTC Amendment | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 1,835 | $104.57 | $191,885.95 |
DisclosureSEC source: 0001209191-18-034732 · doc4a.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,804 F2 · shares: The reporting of this transaction is being amended to reflect the correct number of shares withheld for taxes. F3 · shares: 1,835 shares were withheld from the 4,000 restricted shares that vested on May 30, 2018. These 1,835 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,000 ordinary shares were awarded to Mr. Rosebrough on May 30, 2017 as part of an award of 16,000 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2018. The remaining restrictions on these ordinary shares lapse as follows: 4,000 on May 30, 2019; 4,000 on May 30, 2020; and 4,000 on May 30, 2021. F4 · balance_after: These 48,804 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 29,668 of these Ordinary Shares are restricted. The restrictions on the restricted Ordinary Shares lapse as follows: 4,681 on June 1, 2018; 3,625 on May 28, 2019; 4,000 on May 30, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020 and 4,000 on June 1, 2021. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 20:52 UTC Amendment | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 1,934 | $104.57 | $202,238.38 |
DisclosureSEC source: 0001209191-18-034732 · doc4a.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,639 F1 · shares: 1,934 shares were withheld from the 4,250 restricted shares that vested on May 30, 2018. These 1,934 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,250 ordinary shares were awarded to Mr. Rosebrough on May 30, 2014 as part of an award of 17,000 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2018. F2 · shares: The reporting of this transaction is being amended to reflect the correct number of shares withheld for taxes. Read SEC document |
| May 29, 2018 Filed May 31, 2018 21:15 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 1,626 | $103.97 | $169,055.22 |
DisclosureSEC source: 0001209191-18-034412 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,947 F2 · shares: 1,626 shares were withheld from the 3,625 restricted shares that vested on May 29, 2018. These 1,626 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 3,625 ordinary shares were awarded to Mr. Rosebrough on August 10, 2015 as part of an award of 14,500 restricted shares. These vested shares were valued at the NYSE closing market price on May 29, 2018. The remaining restrictions on these ordinary shares lapse as follows: 3,625 on May 28, 2019. Read SEC document |
| May 29, 2018 Filed May 31, 2018 21:15 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 10,697 | $102.91 | $1,100,828.27 |
DisclosureSEC source: 0001209191-18-034412 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,573 F1 · price: This represents the average sales price of the 10,697 shares sold in the open market. The actual sales prices ranged from $102.73 per share to $103.23 per share. The Reporting Person, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of the separate sales prices Read SEC document |
| May 09, 2018 Filed May 10, 2018 20:36 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 10,000 | $100.50 | $1,005,000.00 |
DisclosureSEC source: 0001209191-18-029265 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,270 F2 · shares: This sale of a total of 10,000 shares, held by the Reporting Person as Trustee of a revocable trust established for his benefit, was pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, as Trustee, effective on August 16, 2017. Read SEC document |
| April 20, 2018 Filed May 9, 2018 19:58 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 3,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-003493 · marketforms-41890.xml · derivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,603 Underlying: Common Stock · 3,603 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units will vest in full on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the next annual meeting, subject to the reporting person serving on the board of the company through the vesting date. F2 · derivative.expiration_date: These Deferred Stock Units will vest in full on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the next annual meeting, subject to the reporting person serving on the board of the company through the vesting date. Read SEC document |
| April 18, 2018 Filed May 10, 2018 20:36 UTC | STERIS plc STE · Entity 158792 | GiftOrdinary Shares, 10 pence par value | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-029265 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 43,806 F3 · ownership.nature: These ordinary shares are held by the Reporting Person's Spouse as Trustee of a revocable trust established for her benefit. Read SEC document |
| April 18, 2018 Filed May 10, 2018 20:36 UTC | STERIS plc STE · Entity 158792 | GiftOrdinary Shares, 10 pence par value | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-029265 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,270 F1 · balance_after: These 73,270 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 41,543 of these Ordinary Shares are restricted. The restrictions on the restricted Ordinary Shares lapse as follows: 3,625 on May 28, 2018; 4,250 on May 30, 2018; 4,000 on May 30, 2018; 4,681 on June 1, 2018; 3,625 on May 28, 2019; 4,000 on May 30, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020 and 4,000 on June 1, 2021. Read SEC document |
| March 28, 2018 Filed Mar 28, 2019 14:03 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 119,000 | Not disclosed Strike: $53.52 | Not disclosed |
DisclosureSEC source: 0001209191-19-021564 · doc4.xml · derivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 119,000 shares Expires 2024-05-30 F4 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 119,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F4 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 119,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 12, 2018 Filed Mar 13, 2018 20:27 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 10,000 | $95.50 | $955,000.00 |
DisclosureSEC source: 0001209191-18-019225 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,270 F1 · shares: This sale of a total of 10,000 shares, held by the Reporting Person as Trustee of a revocable trust established for his benefit, was pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, as Trustee, effective on August 16, 2017. F2 · balance_after: These 53,270 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 41,543 of these Ordinary Shares are restricted. The restrictions on the restricted Ordinary Shares lapse as follows: 3,625 on May 28, 2018; 4,250 on May 30, 2018; 4,000 on May 30, 2018; 4,681 on June 1, 2018; 3,625 on May 28, 2019; 4,000 on May 30, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020 and 4,000 on June 1, 2021. Read SEC document |
| December 06, 2017 Filed Dec 7, 2017 21:41 UTC | STERIS plc STE · Entity 158792 | GiftOrdinary Shares, 10 pence par value | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-064453 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 63,806 F2 · ownership.nature: These ordinary shares are held by the Reporting Person's Spouse as Trustee of a revocable trust established for her benefit. Read SEC document |
| October 04, 2017 Filed Oct 6, 2017 20:32 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 10,000 | $90.50 | $905,000.00 |
DisclosureSEC source: 0001209191-17-056295 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,270 F1 · shares: This sale of a total of 10,000 shares, held by the Reporting Person as Trustee of a revocable trust established for his benefit, was pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, as Trustee, effective on August 14, 2017. F2 · balance_after: These 63,270 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 41,543 of these Ordinary Shares are restricted. The restrictions on the restricted Ordinary Shares lapse as follows: 3,625 on May 28, 2018; 4,250 on May 30, 2018; 4,000 on May 30, 2018; 4,681 on June 1, 2018; 3,625 on May 28, 2019; 4,000 on May 30, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020 and 4,000 on June 1, 2021. Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 20:32 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 10,000 | $85.69 | $856,900.00 |
DisclosureSEC source: 0001209191-17-049401 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,270 F2 · shares: This sale of a total of 10,000 shares, held by the Reporting Person as Trustee of a revocable trust established for his benefit, was pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, as Trustee, effective on August 14, 2017. F3 · balance_after: These 73,270 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 41,543 of these Ordinary Shares are restricted. The restrictions on the restricted Ordinary Shares lapse as follows: 3,625 on May 28, 2018; 4,250 on May 30, 2018; 4,000 on May 30, 2018; 4,681 on June 1, 2018; 3,625 on May 28, 2019; 4,000 on May 30, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020 and 4,000 on June 1, 2021. Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 20:32 UTC | STERIS plc STE · Entity 158792 | GiftOrdinary Shares, 10 pence par value | 878 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-049401 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,270 F1 · shares: This gift of a total of 878 shares, held by the Reporting Person as Trustee of a revocable trust established for his benefit, was pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, as Trustee, effective on August 14, 2017. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 20:34 UTC | STERIS plc STE · Entity 158792 | GiftOrdinary Shares, 10 pence par value | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-044070 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,148 F1 · shares: This gift of a total of 5,000 shares, held by the Reporting Person as Trustee of a revocable trust established for his benefit, was pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, as Trustee, effective on August 16, 2016. F2 · balance_after: These 84,148 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 41,543 of these Ordinary Shares are restricted. The restrictions on the restricted Ordinary Shares lapse as follows: 3,625 on May 28, 2018; 4,250 on May 30, 2018; 4,000 on May 30, 2018; 4,681 on June 1, 2018; 3,625 on May 28, 2019; 4,000 on May 30, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020 and 4,000 on June 1, 2021. Read SEC document |
| June 02, 2017 Filed Jun 5, 2017 20:39 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 10,000 | $80.05 | $800,500.00 |
DisclosureSEC source: 0001209191-17-037749 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,148 F1 · shares: This sale of a total of 10,000 shares, held by the Reporting Person as Trustee of a revocable trust established for his benefit, was pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, as Trustee, effective on August 16, 2016. F2 · price: This represents the average sales price of the 10,000 shares sold in the open market. The actual sales prices ranged from $80.00 per share to $80.16 per share. The Reporting Person, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of the separate sales prices F3 · balance_after: These 89,148 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 41,543 of these Ordinary Shares are restricted. The restrictions on the restricted Ordinary Shares lapse as follows: 3,625 on May 28, 2018; 4,250 on May 30, 2018; 4,000 on May 30, 2018; 4,681 on June 1, 2018; 3,625 on May 28, 2019; 4,000 on May 30, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020 and 4,000 on June 1, 2021. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:40 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 2,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037305 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,148 F2 · shares: 2,222 shares were withheld from the 4,681 restricted shares that vested on June 1, 2017. These 2,222 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,681 shares were awarded to Mr. Rosebrough on June 1, 2016 as part of an award of 18,724 restricted shares. These vested shares were valued at the NYSE closing market price on June 1, 2017. The remaining restrictions on these ordinary shares lapse as follows: 4,681 on June 1, 2018; 4,681 on June 3, 2019 and 4,681 on June 1, 2020. F3 · balance_after: These 99,148 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 41,543 of these Ordinary Shares are restricted. The restrictions on the restricted Ordinary Shares lapse as follows: 3,625 on May 28, 2018; 4,250 on May 30, 2018; 4,000 on May 30, 2018; 4,681 on June 1, 2018; 3,625 on May 28, 2019; 4,000 on May 30, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020 and 4,000 on June 1, 2021. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:40 UTC | STERIS plc STE · Entity 158792 | GiftOrdinary Shares, 10 pence par value | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037305 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,370 F1 · shares: This gift of a total of 5,000 shares, held by the Reporting Person as Trustee of a revocable trust established for his benefit, was pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, as Trustee, effective on August 16, 2016. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 20:44 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 2,966 | $77.56 | $230,042.96 |
DisclosureSEC source: 0001209191-17-036814 · doc4.xml · nonDerivative · entry 5 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,370 F5 · shares: 2,966 shares were withheld from the 6,250 restricted shares that vested on May 31, 2017. These 2,966 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 6,250 ordinary shares were awarded to Mr. Rosebrough on May 31, 2013 as part of an award of 25,000 restricted shares. These vested shares were valued at the NYSE closing market price on May 31, 2017. F6 · balance_after: These 106,370 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 46,224 of these Ordinary Shares are restricted. The restrictions on the restricted Ordinary Shares lapse as follows: 4,681 on June 1, 2017; 3,625 on May 28, 2018; 4,250 on May 30, 2018; 4,000 on May 30, 2018; 4,681 on June 1, 2018; 3,625 on May 28, 2019; 4,000 on May 30, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020 and 4,000 on June 1, 2021. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 20:44 UTC | STERIS plc STE · Entity 158792 | GrantEmployee Stock Option (right to buy) · Derivative | 136,000 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001209191-17-036814 · doc4.xml · derivative · entry 7 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,000 Underlying: Ordinary Shares · 136,000 shares Expires 2027-05-30 F8 · derivative.exercise_date: This option becomes exercisable as follows: 34,000 on May 30, 2018; 34,000 on May 30, 2019; 34,000 on June 1, 2020 and 34,000 on June 1, 2021. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 20:44 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 20,000 | $76.71 | $1,534,200.00 |
DisclosureSEC source: 0001209191-17-036814 · doc4.xml · nonDerivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,336 F4 · price: This represents the average sales price of the 20,000 shares sold in the open market. The actual sales prices ranged from $76.51 per share to $76.98 per share. The Reporting Person, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of the separate sales prices. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 20:44 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 1,191 | $77.07 | $91,790.37 |
DisclosureSEC source: 0001209191-17-036814 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,336 F3 · shares: 1,191 shares were withheld from the 3,625 restricted shares that vested on May 30, 2017. These 1,191 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 3,625 ordinary shares were awarded to Mr. Rosebrough on August 10, 2015 as part of an award of 14,500 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2017. The remaining restrictions on these ordinary shares lapse as follows: 3,625 on May 28, 2018, and 3,625 on May 28, 2019. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 20:44 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 1,397 | $77.07 | $107,666.79 |
DisclosureSEC source: 0001209191-17-036814 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,527 F2 · shares: 1,397 shares were withheld from the 4,250 restricted shares that vested on May 30, 2017. These 1,397 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,250 ordinary shares were awarded to Mr. Rosebrough on May 30, 2014 as part of an award of 17,000 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2017. The remaining restrictions on these ordinary shares lapse as follows: 4,250 on May 30, 2018. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 20:44 UTC | STERIS plc STE · Entity 158792 | GrantOrdinary Shares, 10 pence par value | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036814 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,924 F1 · shares: All 16,000 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on May 30, 2018; 4,000 on May 30, 2019; 4,000 on June 1, 2020 and 4,000 on June 1, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.